Lloyd-Smith Malcolm
Insider CIK 1557146 · CADX SVP, Reg Affairs, Qual & Clin · NBIX Chief Regulatory Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-08 | 2023-02-08 | 701 | $103.83 | $72.8K | 42,337 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 1,015 | $102.16 | $103.7K | 30,213 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-07 | 2023-02-08 | 12,801 | $102.41 | $1.31M | 41,710 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-02-06 | 2023-02-08 | 801 | $105.82 | $84.8K | 29,300 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2023-01-31 | 2023-02-02 | 1,666 | $110.02 | $183.3K | 28,582 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-08-15 | 2022-08-16 | 3,455 | $35.99 | $124.3K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-08-15 | 2022-08-16 | 3,361 | $43.24 | $145.3K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-08-15 | 2022-08-16 | 1,227 | $81.49 | $100.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-08-15 | 2022-08-16 | 1,227 | $81.49 | $100.0K | 26,931 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-08-15 | 2022-08-16 | 3,455 | $35.99 | $124.3K | 22,343 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-08-15 | 2022-08-16 | 3,361 | $43.24 | $145.3K | 25,704 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2022-08-12 | 2022-08-16 | 21,533 | $35.99 | $775.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2022-08-12 | 2022-08-16 | 21,533 | $35.99 | $775.0K | 40,421 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-08-12 | 2022-08-16 | 21,533 | $105.95 | $2.28M | 18,888 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-08 | 2022-02-09 | 701 | $79.53 | $55.8K | 18,731 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 865 | $80.78 | $69.9K | 16,474 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 1,015 | $80.73 | $81.9K | 17,387 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2022-02-07 | 2022-02-09 | 801 | $80.65 | $64.6K | 18,104 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 3,164 | — | $0 | 3,164 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2022-01-31 | 2022-02-02 | 21,546 | — | $0 | 21,546 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-07-27 | 2021-07-29 | 16,709 | $93.80 | $1.57M | 15,801 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-02-10 | 2021-02-12 | 1,700 | $35.99 | $61.2K | 21,533 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-10 | 2021-02-12 | 1,100 | $119.96 | $132.0K | 32,510 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-02-10 | 2021-02-12 | 600 | $35.99 | $21.6K | 33,110 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-10 | 2021-02-12 | 600 | $119.95 | $72.0K | 32,510 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-02-10 | 2021-02-12 | 1,100 | $35.99 | $39.6K | 33,610 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 5,314 | — | $0 | 5,314 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-02-09 | 31,880 | — | $0 | 31,880 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2021-02-08 | 2021-03-29 | 35,035 | — | $0 | 35,035 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 756 | $116.89 | $88.4K | 30,437 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 1,490 | $116.74 | $173.9K | 31,597 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-08 | 2021-02-09 | 1,015 | $116.87 | $118.6K | 32,510 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-02-05 | 2021-02-09 | 865 | $114.15 | $98.7K | 29,675 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-01-26 | 2021-01-27 | 1,100 | $35.99 | $39.6K | 23,233 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-26 | 2021-01-27 | 600 | $119.98 | $72.0K | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-26 | 2021-01-27 | 500 | $35.99 | $18.0K | 29,502 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-26 | 2021-01-27 | 500 | $119.96 | $60.0K | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-26 | 2021-01-27 | 600 | $35.99 | $21.6K | 29,602 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-01-25 | 2021-01-27 | 8,612 | $35.99 | $309.9K | 24,333 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2021-01-25 | 2021-01-27 | 8,958 | $32.99 | $295.5K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-25 | 2021-01-27 | 8,958 | $32.99 | $295.5K | 37,960 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-25 | 2021-01-27 | 4,011 | $35.99 | $144.4K | 33,013 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 4,011 | $119.98 | $481.2K | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2021-01-25 | 2021-01-27 | 4,601 | $35.99 | $165.6K | 33,603 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 4,601 | $119.98 | $552.0K | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2021-01-25 | 2021-01-27 | 8,958 | $119.95 | $1.07M | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-11-12 | 2020-11-16 | 2,257 | $90.73 | $204.8K | 29,002 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-08-05 | 2020-08-07 | 2,257 | $118.86 | $268.3K | 26,971 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-04-24 | 2020-04-28 | 1,934 | $99.45 | $192.3K | 24,941 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2020-02-10 | 2020-02-11 | 15,927 | — | $0 | 17,596 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2020-02-10 | 2020-02-11 | 13,042 | — | $0 | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2020-02-10 | 2020-02-11 | 13,042 | $32.99 | $430.3K | 36,242 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-10 | 2020-02-11 | 13,042 | $104.56 | $1.36M | 23,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2020-02-10 | 2020-02-11 | 15,927 | $81.49 | $1.30M | 39,127 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-10 | 2020-02-11 | 15,927 | $104.56 | $1.67M | 23,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-07 | 2020-02-11 | 1,015 | $103.28 | $104.8K | 23,200 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 6,074 | — | $0 | 6,074 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2020-02-06 | 2020-02-07 | 38,342 | — | $0 | 38,342 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-06 | 2020-02-07 | 1,490 | $101.52 | $151.3K | 22,287 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-05 | 2020-02-07 | 865 | $103.06 | $89.1K | 21,127 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2020-02-05 | 2020-02-07 | 1,083 | $103.03 | $111.6K | 20,455 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2019-10-14 | 2019-10-16 | 9,956 | $15.45 | $153.8K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-10-14 | 2019-10-16 | 9,956 | $90.85 | $904.5K | 19,613 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2019-10-14 | 2019-10-16 | 9,956 | $15.45 | $153.8K | 29,569 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 41,671 | — | $0 | 41,671 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2019-02-07 | 2019-02-08 | 7,712 | — | $0 | 7,712 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-06 | 2019-02-08 | 920 | $83.58 | $76.9K | 19,238 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-05 | 2019-02-06 | 603 | $88.13 | $53.1K | 17,508 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2019-02-05 | 2019-02-06 | 669 | $88.16 | $59.0K | 16,574 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-11-07 | 2018-11-08 | 3,300 | $15.45 | $51.0K | 9,956 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-11-07 | 2018-11-08 | 3,300 | $110.00 | $363.0K | 15,318 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-11-07 | 2018-11-08 | 3,300 | $15.45 | $51.0K | 18,618 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-11-06 | 2018-11-08 | 5,700 | $15.45 | $88.1K | 13,256 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-11-06 | 2018-11-08 | 5,700 | $15.45 | $88.1K | 21,018 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-11-06 | 2018-11-08 | 5,700 | $110.02 | $627.1K | 15,318 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | F Tax w/h | 2018-02-06 | 2018-02-07 | 1,314 | $82.48 | $108.4K | 15,318 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 12,250 | — | $0 | 12,250 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 6,150 | — | $0 | 6,150 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2018-02-05 | 2018-02-07 | 34,750 | — | $0 | 34,750 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-02-05 | 2018-02-07 | 960 | $83.19 | $79.9K | 13,982 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2018-01-02 | 2018-01-04 | 18,084 | $15.45 | $279.4K | 18,956 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2018-01-02 | 2018-01-04 | 18,084 | $77.52 | $1.40M | 13,017 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2018-01-02 | 2018-01-04 | 18,084 | $15.45 | $279.4K | 31,101 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-05-19 | 2017-05-23 | 4,980 | $15.45 | $76.9K | 37,040 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-05-19 | 2017-05-23 | 4,980 | $54.00 | $268.9K | 13,017 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-05-19 | 2017-05-23 | 4,980 | $15.45 | $76.9K | 17,997 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2017-05-18 | 2017-05-23 | 4,980 | $15.45 | $76.9K | 42,020 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-05-18 | 2017-05-23 | 4,980 | $53.26 | $265.2K | 13,017 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2017-05-18 | 2017-05-23 | 4,980 | $15.45 | $76.9K | 17,997 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-04-12 | 2017-04-13 | 204 | $51.23 | $10.5K | 13,017 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-04-12 | 2017-04-13 | 12,861 | $50.41 | $648.3K | 13,221 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-07 | 2017-02-08 | 116 | $44.61 | $5.2K | 1,082 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-06 | 2017-02-08 | 76,800 | — | $0 | 76,800 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2017-02-06 | 2017-02-08 | 10,600 | — | $0 | 10,600 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2017-02-06 | 2017-02-08 | 727 | $43.15 | $31.4K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2016-09-01 | 2016-09-02 | 9,000 | $15.45 | $139.1K | 47,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-09-01 | 2016-09-02 | 9,000 | $50.00 | $450.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2016-09-01 | 2016-09-02 | 9,000 | $15.45 | $139.1K | 9,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise deriv | 2016-05-31 | 2016-06-02 | 9,000 | $15.45 | $139.1K | 56,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | S Sale | 2016-05-31 | 2016-06-02 | 9,000 | $50.00 | $450.0K | 0 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | M Exercise | 2016-05-31 | 2016-06-02 | 9,000 | $15.45 | $139.1K | 9,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 20,500 | — | $0 | 20,500 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 36,400 | — | $0 | 36,400 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2016-02-05 | 2016-02-09 | 7,700 | — | $0 | 7,700 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-02-03 | 2015-02-05 | 25,000 | — | $0 | 25,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2015-02-03 | 2015-02-05 | 22,000 | $32.99 | $725.8K | 22,000 | SEC↗ |
| NBIX NEUROCRINE BIOSCIENCES INC | A Award deriv | 2014-10-01 | 2014-10-01 | 65,000 | — | $0 | 65,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 75,000 | $5.45 | $408.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | $8.60 | $860.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 15,000 | $10.07 | $151.1K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 14,338 | $10.49 | $150.4K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 105,000 | $10.49 | $1.10M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 75,000 | $14.00 | $1.05M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 210,000 | $4.78 | $1.00M | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 14,500 | $4.78 | $69.3K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 35,000 | $5.65 | $197.8K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 10,000 | $3.00 | $30.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | D To issuer deriv | 2014-03-19 | 2014-03-21 | 100,000 | $4.35 | $435.0K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | U Tender | 2014-03-19 | 2014-03-21 | 2,332 | $14.00 | $32.6K | 0 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2014-02-10 | 2014-02-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise deriv | 2013-07-22 | 2013-07-23 | 14,000 | — | $0 | 14,338 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-07-22 | 2013-07-23 | 14,000 | $7.85 | $109.9K | 2,332 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | M Exercise | 2013-07-22 | 2013-07-23 | 14,000 | $3.51 | $49.1K | 16,332 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | S Sale | 2013-06-10 | 2013-06-11 | 4,000 | $7.44 | $29.8K | 2,332 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2013-03-13 | 2013-03-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CADX CADENCE PHARMACEUTICALS IN | A Award deriv | 2012-09-04 | 2012-09-06 | 15,000 | — | $0 | 15,000 | SEC↗ |